Top Medtronic Executive Sells Thousands of Shares!

New insider activity at Medtronic ( (MDT) ) has taken place on September 5, 2025.

EVP & President of Cardiovascular, Kiil Harry Skip, has recently sold 8,605 shares of Medtronic stock, amounting to a total transaction value of $788,047.

Recent Updates on MDT stock

Medtronic’s recent Q1 earnings call highlighted significant developments, including a robust growth in Cardiac Ablation Solutions and Diabetes segments, which contributed to an increased EPS guidance. The Cardiac Ablation Solutions segment nearly reached a 50% growth, driven by high demand for Pulsed Field Ablation systems, particularly in the U.S. and Japan. The Diabetes segment saw an 8% growth, with international markets contributing an 11% increase, attributed to the success of the 780G system and the Simplera Sync sensor. Despite these successes, Medtronic acknowledged challenges in MedSurg and Neuroscience, and ongoing tariff challenges, which are expected to impact finances significantly. The company remains optimistic about its future growth prospects, supported by a strong product pipeline and strategic initiatives, including the planned separation of its Diabetes business. Medtronic’s increased EPS guidance reflects its confidence in its strategic direction and ability to enhance shareholder value.

Spark’s Take on MDT Stock

According to Spark, TipRanks’ AI Analyst, MDT is a Outperform.

Medtronic’s overall stock score of 80 reflects strong financial performance and positive earnings call sentiment, supported by strategic corporate events. While the valuation is on the higher side, the company’s robust growth prospects and stable technical indicators contribute to a favorable outlook.

To see Spark’s full report on MDT stock, click here.

More about Medtronic

YTD Price Performance: 18.13%

Average Trading Volume: 7,390,011

Technical Sentiment Signal: Buy

Current Market Cap: $119.1B